
|Articles|March 31, 2008
Two HIV drugs suspected of producing higher cardiovascular risk
FDA is looking at whether Ziagen and Videx is linked to more heart attacks.
Advertisement
A study has found that abacavir (Ziagen, GlaxoSmithKline) and didanosine (Videx, Bristol-Myers Squibb) are associated with an increased risk of heart attack. So the Food & Drug Administration has issued an early
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































